NEW YORK (GenomeWeb News) – Investigators in the UK and the Netherlands have partnered to use genome sequencing to uncover genomic and biochemical characteristics of four human cancers and to screen drug combinations aimed at creating personalized treatments.

The researchers at the Wellcome Trust Sanger Institute and the Netherlands Cancer Institute, or NKI, have been awarded a £14.5 million ($18.9 million) Synergy grant from the European Research Council to fund the effort, which is part of the ERC's CombatCancer initiative, the European Commission said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.